The current supply of remdesivir which is supposed to be COVID-19 drug and approved by many countries to treat coronavirus will be finished at the end of the month, according to the US Department of Health and Human Services (HHS) official.
According to CNN, Gilead Sciences is ramping up to make more, but it is unclear how much will be available this summer. The US government's last shipment of the drug will go out the week of June 29.
Many countries have approved the use of remdesivir as it gives some positive results. A report of the New England Journal of Medicine shows that two-thirds of a small group of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir.
Previous research has shown that remdesivir alone will not be enough to cure patients. But this medicine had given somehow better improvement to the patient’s heath. Right now there is a shortage of medicine for COVID-19 patients.
